Group 1 - The core point of the article highlights that Tianhe Co., Ltd. (SZ 002999) announced a board meeting on December 12, 2025, to discuss amendments to its articles of association [1] - For the first half of 2025, the company's revenue composition shows that wholesale and retail accounted for 99.89%, while other businesses contributed only 0.11% [1] Group 2 - The article also mentions a controversy surrounding the "Tongyan Needle" product, which reportedly generated sales of 300 million yuan, with concerns raised about the legitimacy of several related parties [1] - There are allegations that the Qian siblings have nearly depleted the resources of Jiangsu Wuzhong, leading to the company's impending delisting [1]

Group 1 - The core revenue composition of Tianhe Co., Ltd. for the year 2024 is 99.83% from wholesale and retail, and 0.17% from other businesses [1] Group 2 - On August 6, 2025, Tianhe Co., Ltd. announced that its director and senior executive, Mr. Luo Xuanbin, plans to reduce his shareholding by up to 530,000 shares, which is 0.15% of the total share capital and 25% of his holdings [3] - Mr. Luo holds approximately 2.1 million shares, representing 0.61% of the total share capital [3] - The reduction will occur through centralized bidding and will not exceed 1% of the total share capital within a 90-day period following the announcement [3]